Pedro A. Piedra

Active 1991–2025

144
Papers
18,539
Citations
81
h-index
140
i10-index

Citations

Citations per year for Pedro A. Piedra1986: 1 citations1995: 3 citations1996: 13 citations1997: 22 citations1998: 19 citations1999: 37 citations2000: 64 citations2001: 100 citations2002: 67 citations2003: 112 citations2004: 128 citations2005: 97 citations2006: 114 citations2007: 77 citations2008: 116 citations2009: 76 citations2010: 63 citations2011: 85 citations2012: 62 citations2013: 82 citations2014: 90 citations2015: 63 citations2016: 111 citations2017: 121 citations2018: 125 citations2019: 408 citations2020: 665 citations2021: 1,032 citations2022: 695 citations2023: 432 citations2024: 773 citations2025: 383 citations2026: 9 citations1987–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,312 citing papers, 30.3% of this breakdownUnited Kingdom: 531 citing papers, 7% of this breakdownChina: 483 citing papers, 6.3% of this breakdownCanada: 276 citing papers, 3.6% of this breakdownAustralia: 247 citing papers, 3.2% of this breakdownGermany: 240 citing papers, 3.2% of this breakdownFrance: 238 citing papers, 3.1% of this breakdownItaly: 225 citing papers, 3% of this breakdownNetherlands: 217 citing papers, 2.9% of this breakdownSpain: 215 citing papers, 2.8% of this breakdownBelgium: 162 citing papers, 2.1% of this breakdownJapan: 152 citing papers, 2% of this breakdown
0%30.3%Other 30.5%

Fields

  • Medicine82.2%
  • Biochemistry, Genetics and Molecular Biology10.6%
  • Immunology and Microbiology3.4%
  • Social Sciences0.6%
  • Environmental Science0.5%
  • Mathematics0.4%
  • Other2.3%

Topics

  • Respiratory viral infections research16.5%
  • SARS-CoV-2 and COVID-19 Research7.9%
  • Influenza Virus Research Studies6.7%
  • Viral gastroenteritis research and epidemiology4.8%
  • Pneumonia and Respiratory Infections4.3%
  • COVID-19 Clinical Research Studies4.2%
  • Other55.6%

Coauthors

All papers

Open in search
  1. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fatimah S. Dawood, New Vaccine Surveillance Network Product Effectiveness Collaborators, Ruth Link‐Gelles, Amanda B. Payne, Ryan E. Wiegand, Ximena Aguilera Correa, Claudia Guevara Pulido, Hanna Grioni, Bonnie Strelitz, Vasanthi Avadhanula, Flor M. Muñoz, Wende Fregoe, S Peri, Anjana Sasidharan, Monika Johnson, Klancie Dauer - MMWR Morbidity and Mortality Weekly Report 2024 cited by 202

  2. Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gayle Langley, Susan I. Gerber - PEDIATRICS 2020 cited by 274

  3. Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 1,245

  4. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masebole Masenya, Federico Martinón‐Torres, Jennifer K. Meece, Terry Nolan, Ayman Osman, Kirsten P. Perrett, Joyce S. Plested, Peter Richmond, Matthew D. Snape, Julie H. Shakib, Vivek Shinde, Tanya Stoney, D. Nigel Thomas, Alan Tita, Michael W. Varner, Manu Vatish, Keith Vrbicky, Judy Wen, Khalequ Zaman, Heather J. Zar, Gregory M. Glenn, Louis Fries - New England Journal of Medicine 2020 cited by 424

  5. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 526

  6. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses — New Vaccine Surveillance Network, United States, 2016–2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bonnie Strelitz, Kirsten Lacombe, Mary E. Moffatt, Jennifer E. Schuster, Chelsea Rohlfs, Miranda Howard, Yesenia Romero, James D. Chappell, Pedro A. Piedra, Vasanthi Avadhanula, Wende Fregoe, Christina Albertin, Robert H. Hickey, Judith M. Martin - MMWR Morbidity and Mortality Weekly Report 2022 cited by 138

  7. Wastewater sequencing reveals community and variant dynamics of the collective human virome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 134

  8. Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

    Authors: , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2015 cited by 296

  9. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Bont - The Lancet Infectious Diseases 2018 cited by 474

  10. Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah Ball, Diya Surie, Jennifer DeCuir, Fatimah S. Dawood, Heidi L. Moline, Ariana P. Toepfer, Benjamin R Clopper, Ruth Link‐Gelles, Amanda B. Payne, Jessie R. Chung, Brendan Flannery, Nathaniel M. Lewis, Samantha M. Olson, Katherine Adams, Mark W. Tenforde, Shikha Garg, Lisa A. Grohskopf, Carrie Reed, Sascha Ellington, CDC Influenza Vaccine Effectiveness Collaborators, CDC Influenza Vaccine Effectiveness Collaborators, Adam S. Lauring, Julie Arndorfer, Daniel Bride, Ithan D. Peltan, Nicholas M. Mohr, David N. Hager, Matthew E. Prekker, Amira Mohamed, Nicholas J. Johnson, Jay S. Steingrub, Akram Khan, Laurence W. Busse, Abhijit Duggal, Jennifer G. Wilson, Nida Qadir, Christopher Mallow, Jennie H. Kwon, Matthew C. Exline, Nathan I. Shapiro, Cristie Columbus, Ivana A. Vaughan, Jarrod Mosier, Basmah Safdar, Estelle S. Harris, James D. Chappell, Laura S Stewart, Sydney A. Swan, Pedro A. Piedra, Leila C. Sahni, Janet A. Englund, Danielle M. Zerr, Robert W. Hickey, John V. Williams, Chelsea Rohlfs, Elizabeth P. Schlaudecker, Dinah Dosdos, Mary E. Moffatt, Jennifer E. Schuster, Kirsten Weltmer, Peter G. Szilagyi, Tara Curley, Jamie Mills, Kiran A. Faryar, Robert A. Salata, Krissy Moehling Geffel, Mary Patricia Nowalk, Kempapura Murthy, Spencer Rose, Michael Smith and 42 more - MMWR Morbidity and Mortality Weekly Report 2024 cited by 86

  11. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E Gács, Krisztina Kalocsai, A. Madarasi, Lajos Kovács, Zoltán Novàk, Zsolt Bene, Shai Ashkenazi, Aviv Goldbart, Lea Bentur, Nadezda Kolosa, Dace Gardovska, Poh Guan Khaw, Teck Hock Toh, Jessie Anne de Bruyne, Kah Kee Tan, Edison Alberto, Junior Sablan Benjamin, Anjanette De Leon, Henryk Szymański, Miroslav Repko, K. Kralinský, Ignacio Salamanca de la Cueva, Carlos Rodrigo Gonzalo de Liria, Federico Martinón‐Torres, María Pilar Cedena Romero, Emilio Monteagudo Montesinos, Jamaree Teeratakulpisarn, Thanyawee Puthanakit, Peninnah Oberdorfer, Boonyarat Warachit, Benedicte Brackeva, Evelyne Dombrecht, Laurent Detalle, C. Fleurinck - The Lancet Respiratory Medicine 2020 cited by 132

  12. Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology

    Authors: , , , , , , , , , , , , , - Water Research 2021 cited by 188

  13. Prospective Multicenter Study of Viral Etiology and Hospital Length of Stay in Children With Severe Bronchiolitis

    Authors: - Archives of Pediatrics and Adolescent Medicine 2012 cited by 405

  14. Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

    Authors: , , , , , - PLoS ONE 2017 cited by 119

  15. Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma

    Authors: , , , , , , , , - Nature Communications 2021 cited by 116

  16. Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants

    Authors: , , , , , , , , , - The Journal of Infectious Diseases 2019 cited by 98

  17. Understanding the Impact of Resistance to Influenza Antivirals

    Authors: , , , , , - Clinical Microbiology Reviews 2021 cited by 81

  18. Baloxavir Marboxil Single-dose Treatment in Influenza-infected Children

    Authors: , , , , , , , , - The Pediatric Infectious Disease Journal 2020 cited by 118

  19. Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis

    Authors: , , , , , , - The Pediatric Infectious Disease Journal 2017 cited by 78

  20. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , New Vaccine Surveillance Network Collaborators, Christina Albertin, Justin Z. Amarin, Heidi Arth, Vasanthi Avadhanula, Dithi Banerjee, C Bartlett, Kristina Betters, Juan E. De Castro, Eva Caudill, Jim Chappell, P. Christopher Cook, Ximenia A Correa, HarshaVardhan Doddapaneni, Dinah Dosdos, Wende Fregoe, Emma C Gauthier, Alexander L. Greninger, Hanna Grioni, Claudia Guevara, Olla Hamdan, Haya Hayek, Miranda Howard, Caymden Hughes, Sara J. Javornik Cregeen, Monika Johnson, Teresa Lin, Laura L. Loftis, Alyssa Masten, Nida Mohammad, Mary E. Moffat, Flor M. Muñoz, Samar Musa, Donna M. Muzny, Amy Ostrow, Amanda B. Payne, Christina Quigley, Collin Ragsdale, Marylin Rice, Chelsea Rohlfs, Anjana Sasidharan, Andrew J. Spieker, Bonnie Strelitz, Anil Surath, Tess Stopczynski, E Chamorro de Vega, Lijuan Wang, Gina Weddle, Krirsten Weltmer, Tricia S. Williams, Danielle M. Zerr - JAMA Pediatrics 2024 cited by 61

  21. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

    Authors: - Vaccine 2003 cited by 228

  22. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics

    Authors: , , , , , , , , , , , , , , , , , , , , - mBio 2022 cited by 62

  23. Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bonnie Strelitz - JAMA Pediatrics 2023 cited by 60

  24. Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Authors: , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2013 cited by 346